ANGLE enters into a contract with Eisai Inc., a global pharmaceutical company, for a pilot study valued at US $250,000.

Name: ANGLE enters into a contract with Eisai Inc., a global pharmaceutical company, for a pilot study valued at US $250,000.
Uploaded: 2024-01-03T15:23:59.324890+00:00
Duration: 68 s
Channel: Vox Markets
Description: ANGLE enters into a contract with Eisai Inc., a global pharmaceutical company, for a pilot study valued at US $250,000.

1 views

1 year ago

Author: Vox Markets

RNS Summary

AGL